Records

Browse every document routed through Assort Design.

Route Filters

• All
• Auto : 3
• Commercial : 16
• Medical Affairs : 39 (selected)
• R&D : 21
• Cross-Functional : 10

Madrigal Expands its MASH Pipeline with Exclusive Global Licensing Agreement for Six Preclinical siRNA Programs February 11, 2026 PDF Version Company advances its leadership in MASH with an expande

One-line summary: Madrigal has expanded its MASH treatment pipeline by licensing six preclinical siRNA programs targeting genetic drivers of disease to complement its foundational therapy Rezdiffra.

Citations: 4  ·  Risk: 1 High / 0 Medium / 0 Low